Skip to main content

Advertisement

SpringerLink
Log in

Incontinence, Voiding Dysfunction, and Other Urologic Complications After Radiotherapy for Gynecologic Malignancies

  • Cancer-Associated Voiding Dysfunction (A Peterson, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Women with newly diagnosed gynecologic cancer will undergo treatment with surgery, radiation, or combination therapy. A considerable proportion of these women will develop urologic complications including urinary incontinence, urinary retention, radiation cystitis, ureteral stricture, or genitourinary fistula. Diagnosis is typically made with a careful history, physical exam, endoscopy, urodynamics, and imaging. Non-surgical and surgical management of urologic complications following radiotherapy is complicated by local tissue damage resulting in inferior success rates when compared to the general population. It is imperative that the patient and physician understand the complexity of treatment and manage expectations accordingly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Erekson EA, Sung VW, DiSilvestro PA, Myers DL. Urinary symptoms and impact on quality of life in women after treatment for endometrial cancer. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(2):159–63. doi:10.1007/s00192-008-0755-z. Study using validated questionnaires that shows worse LUTD in irradiated patients.

  2. Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2015. doi:10.1016/S0140-6736(15)00130-0.

    Google Scholar 

  3. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol. 2004;92(3):744–51. doi:10.1016/j.ygyno.2003.11.048.

    Article  PubMed  Google Scholar 

  4. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. Lancet. 2000;355(9213):1404–11. doi:10.1016/S0140-6736(00)02139-5.

    Article  CAS  PubMed  Google Scholar 

  5. Nout RA, Smit VT, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010;375(9717):816–23. doi:10.1016/S0140-6736(09)62163-2.

    Article  CAS  PubMed  Google Scholar 

  6. Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment. Cancer. 2005;104(6):1129–37. doi:10.1002/cncr.20445.

    Article  PubMed  Google Scholar 

  7. Ko EM, Funk MJ, Clark LH, Brewster WR. Did GOG99 and PORTEC1 change clinical practice in the United States? Gynecol Oncol. 2013;129(1):12–7. doi:10.1016/j.ygyno.2013.01.020.

    Article  PubMed  Google Scholar 

  8. Delaney G, Jacob S, Barton M. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma. Cancer. 2004;101(4):671–81. doi:10.1002/cncr.20444.

    Article  PubMed  Google Scholar 

  9. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol Oncol. 1999;73.2:177–83. doi:10.1006/gyno.1999.5387.

    Article  Google Scholar 

  10. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990;38(3):352–7.

    Article  CAS  PubMed  Google Scholar 

  11. Rogers L, Siu SSN, Luesley D, Bryant A, Dickinson HO. Radiotherapy and chemoradiation after surgery for early cervical cancer. Cochrane Libr. 2012. doi:10.1002/14651858.CD007583.pub3.

    Google Scholar 

  12. Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan AN. Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys. 2013;87(1):111–9. doi:10.1016/j.ijrobp.2013.05.033.

    Article  PubMed  Google Scholar 

  13. Berek JS, Hacker NF. Gynecologic oncology. 6th ed. Philadelphia: Wolters Kluwer; 2015.

    Google Scholar 

  14. Hiniker SM, Roux A, Murphy JD, Harris JP, Tran PT, Kapp DS, et al. Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes. Gynecol Oncol. 2013;131(2):380–5. doi:10.1016/j.ygyno.2013.08.012.

    Article  PubMed  Google Scholar 

  15. Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38(3):309–14.

    Article  CAS  PubMed  Google Scholar 

  16. Mahner S, Jueckstock J, Hilpert F, Neuser P, Harter P, de Gregorio N, Hasenburg A, Sehouli J, Habermann A, Hillemanns P, Fuerst S. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Ntnl Cancer Inst. 2015: 107.3. doi:10.1093/jnci/dju426.

  17. Swartz MA, Porter MP, Lin DW, Weiss NS. Incidence of primary urethral carcinoma in the United States. Urology. 2006;68(6):1164–8. doi:10.1016/j.urology.2006.08.1057.

    Article  PubMed  Google Scholar 

  18. Johnson DE, O’Connell JR. Primary carcinoma of female urethra. Urology. 1983;21(1):42–5. doi:10.1016/0090-4295(83)90120-6.

    Article  CAS  PubMed  Google Scholar 

  19. Micaily B, Dzeda MF, Miyamoto CT, Brady LW. Brachytherapy for cancer of the female urethra. Semin Surg Oncol. Wiley. 1997; 13(3). doi:10.1002/(SICI)1098-2388(199705/06)13:3<208::AID-SSU9>3.0.CO;2-B.

  20. Kuettel MR, Parda DS, Harter WK, Rodgers JE, Lynch JH. Treatment of female urethral carcinoma in medically inoperable patients using external beam irradiation and high dose rate intracavitary brachytherapy. J Urol. 1997;157(5):1669–71.

    Article  CAS  PubMed  Google Scholar 

  21. Dalbagni G, Donat SM, Eschwege P, Herr HW, Zelefsky MJ. Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra. J Urol. 2001;166(5):1759–61.

    Article  CAS  PubMed  Google Scholar 

  22. Dayyani F, Hoffman K, Eifel P, Guo C, Vikram R, Pagliaro LC, et al. Management of advanced primary urethral carcinomas. BJU Int. 2014;114(1):25–31.

    Article  PubMed  Google Scholar 

  23. Garden AS, Zagars GK, Delclos L. Primary carcinoma of the female urethra results of radiation therapy. Cancer. 1993;71(10):3102–8.

    Article  CAS  PubMed  Google Scholar 

  24. Chen LA, Kim J, Boucher K, Terakedis B, Williams B, Nickman NA, et al. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers. Gynecol Oncol. 2015;136(3):521–8.

    Article  PubMed  Google Scholar 

  25. Kanai A, de Groat W, Birder L, Chai T, Hultgren S, Fowler C, et al. Symposium report on urothelial dysfunction: pathophysiology and novel therapies. J Urol. 2006;175(5):1624–9. doi:10.1016/S0022-5347(05)00977-8.

    Article  CAS  PubMed  Google Scholar 

  26. Zwaans BMM, Chancellor MB, Lamb LE. Modeling and treatment of radiation cystitis. Urology. 2015. doi:10.1016/j.urology.2015.11.001.

    PubMed  Google Scholar 

  27. Plotti F, Angioli R, Zullo MA, Sansone M, Altavilla T, Antonelli E, et al. Update on urodynamic bladder dysfunctions after radical hysterectomy for cervical cancer. Crit Rev Oncol/Hematol. 2011;80(2):323–9. doi:10.1016/j.critrevonc.2010.12.004.

    Article  Google Scholar 

  28. Lind H, Waldenström AC, Dunberger G, Al-Abany M, Alevronta E, Johansson KA, et al. Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study. Br J Cancer. 2011;105(6):737–45. doi:10.1038/bjc.2011.315.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Korfage IJ, Essink-Bot ML, Mols F, van de Poll-Franse L, Kruitwagen R, van Ballegooijen M. Health-related quality of life in cervical cancer survivors: a population-based survey. Int J Radiat Oncol Biol Phys. 2009;73(5):1501–9.

    Article  PubMed  Google Scholar 

  30. Nout RA, van de Poll-Franse LV, Lybeert ML, Wárlám-Rodenhuis CC, Jobsen JJ, Mens JW, et al. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. J Clin Oncol. 2011;29(13):1692–700. Randomized controlled trial showing increased LUTD in irradiated patients, specifically increased incontinence.

  31. Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1995;31(5):1257–80.

    Article  CAS  PubMed  Google Scholar 

  32. Perez CA, Brady LW (Eds.), Principles and practice of radiation oncology (3rd ed.), Lippincott-Raven, Philadelphia. 1998: 1733–1834.

  33. Levenback C, Eifel PJ, Burke TW, Morris M, Gershenson DM. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994;55(2):206–10.

    Article  CAS  PubMed  Google Scholar 

  34. Antonakopoulos GN, Hicks RM, Berry RJ. The subcellular basis of damage to the human urinary bladder induced by irradiation. J Pathol. 1984;143(2):103–16.

    Article  CAS  PubMed  Google Scholar 

  35. Thiruchelvam N, Cruz F, Kirby M, Tubaro A, Chapple C, Sievert KD. A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment. BJU Int. 2015;116(6):853–61. doi:10.1111/bju.13078.

    Article  PubMed  Google Scholar 

  36. Donovan KA, Boyington AR, Judson PL, Wyman JF. Bladder and bowel symptoms in cervical and endometrial cancer survivors. Psycho-Oncology. 2014;23(6):672–8. doi:10.1002/pon.3461.

    Article  PubMed  PubMed Central  Google Scholar 

  37. de Boer SM, Nout RA, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, et al. Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship: results from the randomized PORTEC-2 trial. Int J Radiat Oncol Biol Phys. 2015;93(4):797–809. doi:10.1016/j.ijrobp.2015.08.023. Randomized controlled trial showing OAB and incontinence in patients treated with both EBRT and brachytherapy.

  38. Herwig R, Bruns F, Strasser H, Pinggera GM, Micke O, Rehder P, et al. Late urologic effects after adjuvant irradiation in stage I endometrial carcinoma. Urology. 2004;63(2):354–8.

    Article  CAS  PubMed  Google Scholar 

  39. Wein AJ. Pathophysiology and classification of lower urinary tract dysfunction. 11th ed. Philadelphia: Elsevier; 2016. p. 1685–96. Describes established classification system for incontinence.

  40. Parkin DE, Davis JA, Symonds RP. Urodynamic findings following radiotherapy for cervical carcinoma. Br J Urol. 1988;61(3):213–7.

    Article  CAS  PubMed  Google Scholar 

  41. Katepratoom C, Manchana T, Amornwichet N. Lower urinary tract dysfunction and quality of life in cervical cancer survivors after concurrent chemoradiation versus radical hysterectomy. Int Urogynecol J. 2014;25(1):91–6. doi:10.1007/s00192-013-2151-6.

    Article  PubMed  Google Scholar 

  42. Lin HH, Sheu BC, Lo MC, Huang SC. Abnormal urodynamic findings after radical hysterectomy or pelvic irradiation for cervical cancer. Int J Gynecol Obstet. 1998;63(2):169–74.

    Article  CAS  Google Scholar 

  43. Gilbaz E, Gungor UF, Aslay I, Yalcin O. The effects of simple and radical hysterectomy and radiotherapy on lower urinary tract symptoms and urodynamics. Eur J Gynaecol Oncol. 2012;34(3):248–53.

    Google Scholar 

  44. Anderson KM, Davis K, Flynn BJ. Urinary incontinence and pelvic organ prolapse. Med Clin N Am. 2015;99(2):405–16. doi:10.1016/j.mcna.2014.11.011.

    Article  PubMed  Google Scholar 

  45. Flores D, Mock S, Broghammer JA, Griebling TL, Dmochowski RR, Padmanabhan P. Onabotulinumtoxin A in patients with a history of prior pelvic radiation therapy. Annual Society of Female Urology and Urodynamics, Scottsdale, AZ, February 2015 and Annual American Urologic Association meeting, New Orleans. 2015.

  46. Flynn BJ, Yap WT. Pubovaginal sling using allograft fascia lata versus autograft fascia for all types of stress urinary incontinence: 2-year minimum followup. J Urol. 2002;167(2):608–12.

    Article  PubMed  Google Scholar 

  47. Thomas K, Venn SN, Mundy AR. Outcome of the artificial urinary sphincter in female patients. J Urol. 2002;167(4):1720–2.

    Article  CAS  PubMed  Google Scholar 

  48. Angioli R, Penalver M, Muzii L, Mendez L, Mirhashemi R, Bellati F, et al. Guidelines of how to manage vesicovaginal fistula. Crit Rev Oncol/Hematol. 2003;48(3):295–304.

    Article  Google Scholar 

  49. Zoubek J, McGuire EJ, Noll F, DeLancey JO. The late occurrence of urinary tract damage in patients successfully treated by radiotherapy for cervical carcinoma. J Urol. 1989;141(6):1347–9.

    CAS  PubMed  Google Scholar 

  50. Narayanan P, Nobbenhuis M, Reynolds KM, Sahdev A, Reznek RH, Rockall AG. Fistulas in malignant gynecologic disease: etiology, imaging, and management. Radiographics. 2009;29(4):1073–83.

    Article  PubMed  Google Scholar 

  51. Abrams, P., De Vries, C., Elneil, S., Emasu, A., Esegbono, G., Gueye, S., Mohammad, R., Mourad, S., Hilton, P., Pickard, R., Stanford, E.. Fistula: In Abrams P, Cardozo L, Khoury S, Wein A (Eds.): Incontinence: Proceedings from the 5th International Consultation on Incontinence. Plymouth UK: Health Publications, 2013, pp.1529-1568

  52. Pshak T, Nikolavsky D, Terlecki R, Flynn BJ. Is tissue interposition always necessary in transvaginal repair of benign, recurrent vesicovaginal fistulae? Urology. 2013;82(3):707–12. doi:10.1016/j.urology.2013.03.076. Retrospective review discussing need for tissue interposition in vesicovaginal fistula repair.

  53. Pushkar DY, Dyakov VV, Kasyan GR. Management of radiation-induced vesicovaginal fistula. Eur Urol. 2009;55(1):131–8. doi:10.1016/j.eururo.2008.04.044.

    Article  PubMed  Google Scholar 

  54. McLntyre JF, Eifel PJ, Levenback C, Oswald MJ. Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix. Cancer. 1995;75(3):836–43.

    Article  Google Scholar 

  55. Windsperger A, Larke R, Higuchi T, Maroni P, Flynn B. PD3-09 ureteral reconstruction or benign stricture disease: a single institution 11 year experience with simple and complex reconstructive techniques. J Urol. 2014;4(191), e23.

    Article  Google Scholar 

  56. Cochrane JP, Yarnold JR, Slack WW. The surgical treatment of radiation injuries after radiotherapy for uterine carcinoma. Br J Surg. 1981;68(1):25–8.

    Article  CAS  PubMed  Google Scholar 

  57. Wilkin M, Horwitz G, Seetharam A, Hartenbach E, Schink JC, Bruskewitz R, Jarrard DF. Long-term complications associated with the Indiana pouch urinary diversion in patients with recurrent gynecologic cancers after high-dose radiation. In Urologic Oncology: Seminars and Original Investigations 2005; 23(1): 12–15. Elsevier.

  58. Kisner CD, Kesner KM. Use of the transverse colon conduit for vesicovaginal fistula in late‐stage carcinoma of the cervix. Br J Urol. 1987;59(3):234–8.

    Article  CAS  PubMed  Google Scholar 

  59. Maier U, Ehrenbock PM, Hofbauer J. Late urological complications and malignancies after curative radiotherapy for gynecological carcinomas: a retrospective analysis of 10,709 patients. J Urol. 1997;158(3):814–7.

    Article  CAS  PubMed  Google Scholar 

  60. Arai T, Nakano T, Fukuhisa K, Kasamatsu T, Tsunematsu R, Masubuchi K, et al. Second cancer after radiation therapy for cancer of the uterine cervix. Cancer. 1991;67(2):398–405.

    Article  CAS  PubMed  Google Scholar 

  61. Duncan RE, Bennett DW, Evans AT, Aron BS, Schellhas HF. Radiation-induced bladder tumors. J Urol. 1977;118(1):43–5.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Boston University, Boston, MA, USA

    Garrick Greear

  2. Division of Gynecology-Oncology, Department of Obstetrics and Gynecology, University of Colorado Denver, Denver, CO, USA

    Carolyn Lefkowits

  3. Division of Urology, Department of Surgery, University of Colorado Denver, Academic Office One Bldg, room L15-5602, 12631 East 17th Ave., Box C319, Aurora, CO, 80045, USA

    Lisa M. Parrillo & Brian J. Flynn

Authors
  1. Garrick Greear
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carolyn Lefkowits
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lisa M. Parrillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Brian J. Flynn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian J. Flynn.

Ethics declarations

Conflict of Interest

Drs Greear, Lefkowits, Parrillo, and Flynn declare no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the author.

Additional information

This article is part of the Topical Collection on Cancer-Associated Voiding Dysfunction

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Greear, G., Lefkowits, C., Parrillo, L.M. et al. Incontinence, Voiding Dysfunction, and Other Urologic Complications After Radiotherapy for Gynecologic Malignancies. Curr Bladder Dysfunct Rep 11, 88–97 (2016). https://doi.org/10.1007/s11884-016-0354-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-016-0354-7

Keywords

Search

Navigation